BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8122378)

  • 1. A thymidine kinase-negative HSV-1 strain establishes a persistent infection in SCID mice that features uncontrolled peripheral replication but only marginal nervous system involvement.
    Valyi-Nagy T; Gesser RM; Raengsakulrach B; Deshmane SL; Randazzo BP; Dillner AJ; Fraser NW
    Virology; 1994 Mar; 199(2):484-90. PubMed ID: 8122378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal control of herpes simplex virus latency.
    Tenser RB; Edris WA; Hay KA
    Virology; 1993 Aug; 195(2):337-47. PubMed ID: 8393231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral inoculation of SCID mice with an attenuated herpes simplex virus-1 strain causes persistent enteric nervous system infection and gastric ulcers without direct mucosal infection.
    Gesser RM; Valyi-Nagy T; Fraser NW; Altschuler SM
    Lab Invest; 1995 Dec; 73(6):880-9. PubMed ID: 8558851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymidine Kinase-Negative Herpes Simplex Virus 1 Can Efficiently Establish Persistent Infection in Neural Tissues of Nude Mice.
    Huang CY; Yao HW; Wang LC; Shen FH; Hsu SM; Chen SH
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27974554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
    Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
    Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of latent herpes simplex virus type 1 infection in resistant, sensitive, and immunodeficient mouse strains.
    Ellison AR; Yang L; Voytek C; Margolis TP
    Virology; 2000 Mar; 268(1):17-28. PubMed ID: 10683323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological properties of herpes simplex virus 2 replication-defective mutant strains in a murine nasal infection model.
    Jones CA; Taylor TJ; Knipe DM
    Virology; 2000 Dec; 278(1):137-50. PubMed ID: 11112490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of virus-encoded thymidine kinase suppresses herpes simplex virus replication in vitro and in vivo.
    Watkins AM; Dunford PJ; Moffatt AM; Wong-Kai-In P; Holland MJ; Pole DS; Thomas GM; Martin J; Roberts NA; Mulqueen MJ
    Antivir Chem Chemother; 1998 Jan; 9(1):9-18. PubMed ID: 9875372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restricted herpes simplex virus type 1 gene expression within sensory neurons in the absence of functional B and T lymphocytes.
    Gesser RM; Valyi-Nagy T; Fraser NW
    Virology; 1994 May; 200(2):791-5. PubMed ID: 8178461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of the herpes simplex virus UL24 gene for productive ganglionic infection in mice.
    Jacobson JG; Chen SH; Cook WJ; Kramer MF; Coen DM
    Virology; 1998 Mar; 242(1):161-9. PubMed ID: 9501052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes simplex virus type 1 latency in the murine nervous system is associated with oxidative damage to neurons.
    Valyi-Nagy T; Olson SJ; Valyi-Nagy K; Montine TJ; Dermody TS
    Virology; 2000 Dec; 278(2):309-21. PubMed ID: 11118355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent elevated expression of cytokine transcripts in ganglia latently infected with herpes simplex virus in the absence of ganglionic replication or reactivation.
    Chen SH; Garber DA; Schaffer PA; Knipe DM; Coen DM
    Virology; 2000 Dec; 278(1):207-16. PubMed ID: 11112495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spread and replication of and immune response to gamma134.5-negative herpes simplex virus type 1 vectors in BALB/c mice.
    Broberg EK; Peltoniemi J; Nygårdas M; Vahlberg T; Röyttä M; Hukkanen V
    J Virol; 2004 Dec; 78(23):13139-52. PubMed ID: 15542666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of generation and replication of acyclovir-resistant herpes simplex virus by a sensitive virus.
    Okuda T; Kurokawa M; Matsuo K; Honda M; Niimura M; Shiraki K
    J Med Virol; 2004 Jan; 72(1):112-20. PubMed ID: 14635018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
    Wiewrodt R; Amin K; Kiefer M; Jovanovic VP; Kapoor V; Force S; Chang M; Lanuti M; Black ME; Kaiser LR; Albelda SM
    Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of herpes simplex virus in the trigeminal and olfactory systems of the mouse central nervous system during acute and latent infections by in situ hybridization.
    Stroop WG; Rock DL; Fraser NW
    Lab Invest; 1984 Jul; 51(1):27-38. PubMed ID: 6330452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir.
    Howard BD; Boenicke L; Schniewind B; Henne-Bruns D; Kalthoff H
    Cancer Gene Ther; 2000 Jun; 7(6):927-38. PubMed ID: 10880025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurovirulence and latency of drug-resistant clinical herpes simplex viruses in animal models.
    Dambrosi S; Martin M; Yim K; Miles B; Canas J; Sergerie Y; Boivin G
    J Med Virol; 2010 May; 82(6):1000-6. PubMed ID: 20419814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity.
    Wildner O; Morris JC
    Cancer Res; 2000 Aug; 60(15):4167-74. PubMed ID: 10945625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient gene delivery into epstein-barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): A gene therapy model for EBV-related B cell malignancy.
    Suzuki T; Piche A; Kasono K; Xiang J; Gomez-Navarro J; Moriuchi S; Krisky DM; Oligino T; Glorioso JC; Curiel TJ; Curiel DT
    Biochem Biophys Res Commun; 1998 Nov; 252(3):686-90. PubMed ID: 9837767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.